Logos Global Management LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $756 Million distributed in 55 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ideaya Biosciences, Inc. with a value of $66.5M, Revolution Medicines, Inc. with a value of $54.4M, Janux Therapeutics, Inc. with a value of $45.4M, Olema Pharmaceuticals, Inc. with a value of $38.3M, and Vaxcyte, Inc. with a value of $34.3M.

Examining the 13F form we can see an decrease of $310M in the current position value, from $1.07B to 756M.

Logos Global Management LP is based out at San Francisco, CA

Below you can find more details about Logos Global Management LP portfolio as well as his latest detailed transactions.

Portfolio value $756 Million
Healthcare: $756 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 55
  • Current Value $756 Million
  • Prior Value $1.07 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 14, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 15 stocks
  • Additional Purchases 9 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.